A Phase 3, Interventional, Randomized, Multicenter, Open-Label Study of DCC-2618 vs Sunitinib in Patients with Advanced Gastrointestinal Stromal Tumors after Treatment with Imatinib
Clinical Trial Grant
Awarded By
Deciphera Pharmaceuticals, LLC
Start Date
March 27, 2019
End Date
March 31, 2024
Awarded By
Deciphera Pharmaceuticals, LLC
Start Date
March 27, 2019
End Date
March 31, 2024